Alnylam Pharmaceuticals, Inc. (BMV:ALNY)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	1,119,350	565,734	447,732	547,634	378,973	281,378
Market Cap Growth	63.04%	26.36%	-18.24%	44.51%	34.68%	17.11%
Enterprise Value	1,117,165	538,951	425,874	530,636	351,480	255,530
PE Ratio	-	-107.94	-54.38	-25.55	-23.55	-17.42
Forward PE	73.88	-	-	-	-	-
PS Ratio	24.11	13.53	13.17	28.39	24.14	30.70
PB Ratio	236.86	453.50	-109.13	-186.13	34.65	14.89
P/TBV Ratio	4330.78	447.73	-108.36	-182.78	34.15	14.71
P/FCF Ratio	-	-714.37	574.04	-48.02	-28.38	-22.08
P/OCF Ratio	-	-3660.27	231.17	-54.41	-31.76	-24.61
EV/Sales Ratio	24.47	12.89	12.53	27.51	22.39	27.88
EV/EBITDA Ratio	-	-241.10	-100.40	-38.53	-30.54	-18.23
EV/EBIT Ratio	-	-163.86	-81.16	-36.35	-26.67	-16.59
EV/FCF Ratio	-1137.31	-680.55	546.02	-46.53	-26.32	-20.05
Debt / Equity Ratio	4.99	18.69	-5.73	-8.08	1.63	0.48
Debt / EBITDA Ratio	-10.49	-10.78	-5.72	-1.78	-1.61	-0.69
Debt / FCF Ratio	-24.90	-30.43	31.12	-2.15	-1.39	-0.76
Asset Turnover	0.56	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	5.36	3.86	2.85	1.57	1.73	1.19
Quick Ratio	2.63	2.61	2.86	3.16	3.79	4.23
Current Ratio	2.80	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	-277.05%	620.74%	225.30%	-522.27%	-106.14%	-69.49%
Return on Assets (ROA)	-4.74%	-5.54%	-7.53%	-21.76%	-20.09%	-28.47%
Return on Capital (ROIC)	-17.05%	-19.47%	-27.44%	-76.67%	-64.77%	-86.50%
Return on Capital Employed (ROCE)	-5.70%	-5.98%	-10.01%	-27.42%	-24.57%	-34.06%
Earnings Yield	-0.54%	-0.93%	-1.84%	-3.91%	-4.25%	-5.74%
FCF Yield	-0.09%	-0.14%	0.17%	-2.08%	-3.52%	-4.53%
Buyback Yield / Dilution	-0.64%	-1.00%	-0.61%	-0.88%	-1.21%	-1.98%
Total Shareholder Return	-	-1.00%	-0.61%	-0.88%	-1.21%	-1.98%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.